155 related articles for article (PubMed ID: 16531745)
1. Familial combined hyperlipidemia: upstream transcription factor 1 and beyond.
Lee JC; Lusis AJ; Pajukanta P
Curr Opin Lipidol; 2006 Apr; 17(2):101-9. PubMed ID: 16531745
[TBL] [Abstract][Full Text] [Related]
2. Genetics of familial combined hyperlipidemia.
Naukkarinen J; Ehnholm C; Peltonen L
Curr Opin Lipidol; 2006 Jun; 17(3):285-90. PubMed ID: 16680034
[TBL] [Abstract][Full Text] [Related]
3. Familial combined hyperlipidemia is associated with upstream transcription factor 1 (USF1).
Pajukanta P; Lilja HE; Sinsheimer JS; Cantor RM; Lusis AJ; Gentile M; Duan XJ; Soro-Paavonen A; Naukkarinen J; Saarela J; Laakso M; Ehnholm C; Taskinen MR; Peltonen L
Nat Genet; 2004 Apr; 36(4):371-6. PubMed ID: 14991056
[TBL] [Abstract][Full Text] [Related]
4. Familial combined hyperlipidemia in Mexicans: association with upstream transcription factor 1 and linkage on chromosome 16q24.1.
Huertas-Vazquez A; Aguilar-Salinas C; Lusis AJ; Cantor RM; Canizales-Quinteros S; Lee JC; Mariana-Nuñez L; Riba-Ramirez RM; Jokiaho A; Tusie-Luna T; Pajukanta P
Arterioscler Thromb Vasc Biol; 2005 Sep; 25(9):1985-91. PubMed ID: 15976322
[TBL] [Abstract][Full Text] [Related]
5. Unraveling the complex genetics of familial combined hyperlipidemia.
Suviolahti E; Lilja HE; Pajukanta P
Ann Med; 2006; 38(5):337-51. PubMed ID: 16938803
[TBL] [Abstract][Full Text] [Related]
6. Potential role of upstream stimulatory factor 1 gene variant in familial combined hyperlipidemia and related disorders.
Auer S; Hahne P; Soyal SM; Felder T; Miller K; Paulmichl M; Krempler F; Oberkofler H; Patsch W
Arterioscler Thromb Vasc Biol; 2012 Jun; 32(6):1535-44. PubMed ID: 22460558
[TBL] [Abstract][Full Text] [Related]
7. USF1 implicated in the aetiology of familial combined hyperlipidaemia and the metabolic syndrome.
Shoulders CC; Naoumova RP
Trends Mol Med; 2004 Aug; 10(8):362-5. PubMed ID: 15310455
[TBL] [Abstract][Full Text] [Related]
8. Genetic dissection of familial combined hyperlipidemia.
Eurlings PM; van der Kallen CJ; Geurts JM; van Greevenbroek MM; de Bruin TW
Mol Genet Metab; 2001; 74(1-2):98-104. PubMed ID: 11592807
[TBL] [Abstract][Full Text] [Related]
9. [Familial combined hyperlipidemia].
Sasaki J
Nihon Rinsho; 1999 Dec; 57(12):2776-81. PubMed ID: 10638212
[TBL] [Abstract][Full Text] [Related]
10. Novel drugs in familial combined hyperlipidemia: lessons from type 2 diabetes mellitus.
Brouwers MC; de Graaf J; van Greevenbroek MM; Schaper N; Stehouwer CD; Stalenhoef AF
Curr Opin Lipidol; 2010 Dec; 21(6):530-8. PubMed ID: 20739883
[TBL] [Abstract][Full Text] [Related]
11. Relationship between familial combined hyperlipidemia and insulin resistance.
Jackuliaková D; Vaverková H; Karásek D
Vnitr Lek; 2008 Nov; 54(11):1045-53. PubMed ID: 19069677
[TBL] [Abstract][Full Text] [Related]
12. [Secondary disorders of lipid metabolism, metabolic syndrome and familial combined hyperlipidemia].
Steinmetz A; Schäfer JR
Wien Med Wochenschr; 1994; 144(12-13):299-307. PubMed ID: 8650933
[TBL] [Abstract][Full Text] [Related]
13. Variants in the PPARgamma gene affect fatty acid and glycerol metabolism in familial combined hyperlipidemia.
Eurlings PM; van der Kallen CJ; Vermeulen VM; de Bruin TW
Mol Genet Metab; 2003 Nov; 80(3):296-301. PubMed ID: 14680975
[TBL] [Abstract][Full Text] [Related]
14. Familial combined hyperlipidemia: controversial aspects of its diagnosis and pathogenesis.
Aguilar Salinas CA; Zamora M; Gómez-Díaz RA; Mehta R; Gómez Pérez FJ; Rull JA
Semin Vasc Med; 2004 May; 4(2):203-9. PubMed ID: 15478042
[TBL] [Abstract][Full Text] [Related]
15. USF1 and dyslipidemias: converging evidence for a functional intronic variant.
Naukkarinen J; Gentile M; Soro-Paavonen A; Saarela J; Koistinen HA; Pajukanta P; Taskinen MR; Peltonen L
Hum Mol Genet; 2005 Sep; 14(17):2595-605. PubMed ID: 16076849
[TBL] [Abstract][Full Text] [Related]
16. Functional variant disrupts insulin induction of USF1: mechanism for USF1-associated dyslipidemias.
Naukkarinen J; Nilsson E; Koistinen HA; Söderlund S; Lyssenko V; Vaag A; Poulsen P; Groop L; Taskinen MR; Peltonen L
Circ Cardiovasc Genet; 2009 Oct; 2(5):522-9. PubMed ID: 20031629
[TBL] [Abstract][Full Text] [Related]
17. A systems genetics approach implicates USF1, FADS3, and other causal candidate genes for familial combined hyperlipidemia.
Plaisier CL; Horvath S; Huertas-Vazquez A; Cruz-Bautista I; Herrera MF; Tusie-Luna T; Aguilar-Salinas C; Pajukanta P
PLoS Genet; 2009 Sep; 5(9):e1000642. PubMed ID: 19750004
[TBL] [Abstract][Full Text] [Related]
18. Evidence that non-lipid cardiovascular risk factors are associated with high prevalence of coronary artery disease in patients with heterozygous familial hypercholesterolemia or familial combined hyperlipidemia.
Skoumas I; Masoura C; Pitsavos C; Tousoulis D; Papadimitriou L; Aznaouridis K; Chrysohoou C; Giotsas N; Toutouza M; Tentolouris C; Antoniades C; Stefanadis C
Int J Cardiol; 2007 Oct; 121(2):178-83. PubMed ID: 17188767
[TBL] [Abstract][Full Text] [Related]
19. Upstream transcription factor 1 influences plasma lipid and metabolic traits in mice.
Wu S; Mar-Heyming R; Dugum EZ; Kolaitis NA; Qi H; Pajukanta P; Castellani LW; Lusis AJ; Drake TA
Hum Mol Genet; 2010 Feb; 19(4):597-608. PubMed ID: 19995791
[TBL] [Abstract][Full Text] [Related]
20. [Familial combined hyperlipidemia].
Bredie SJ; Stalenhoef AF
Ned Tijdschr Geneeskd; 1996 Dec; 140(50):2528. PubMed ID: 9005339
[No Abstract] [Full Text] [Related]
[Next] [New Search]
